VanEck Associates’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Buy
+3,888
New +$286K ﹤0.01% 1293

Other funds holding CGON

VanEck Associates's CGON Position: Q3 2026 in Review

VanEck Associates opened a new position in CG Oncology (CGON) in Q3 2026: 3,888 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings.

232 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • VanEck Associates held 3,888 shares of CG Oncology worth $276K as of Q3 2026.
  • CG Oncology was a new VanEck Associates position in Q3 2026.
  • CG Oncology made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1293 holding.
  • 232 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.